Showing results (621-630 of 651) with videos related to

Sort By:
Pageof 66
European Journal of Haematology|March 25, 2023
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter studyOfrat Beyar Katz, Chava Perry, Sigal Grisariu-Greenzaid, et al.
Transplantation and Cellular Therapy|July 2, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort StudyRon Ram, David Hagin, Nino Kikozashvilli, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 22, 2024
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trialsEline H Ploumen, Edimir Semedo, Carine J M Doggen, et al.
American Heart Journal|April 15, 2018
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trialLiefke C van der Heijden, Marlies M Kok, Paolo Zocca, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 11, 2021
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trialEline H Ploumen, Rosaly A Buiten, Paolo Zocca, et al.
Journal of the American Heart Association|January 12, 2024
Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding RiskRan Kornowski, Maayan Konigstein, Michael Jonas, et al.
JACC. Cardiovascular Interventions|May 9, 2020
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 YearsRosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
Lancet (London, England)|September 27, 2018
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trialClemens von Birgelen, Paolo Zocca, Rosaly A Buiten, et al.
International Journal of Cardiology|November 5, 2020
Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trialsEline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
Transplantation and Cellular Therapy|June 12, 2026
Impact of Bridging Response on Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell LymphomaBeatriz Wills, Sarah Samorodnitsky, Samantha Brown, et al.
Pageof 66